ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 113 filers reported holding ARRAY BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,212,000 | +71.2% | 26,216 | -10.1% | 0.00% | +50.0% |
Q1 2019 | $708,000 | +100.6% | 29,160 | +13.4% | 0.00% | +100.0% |
Q4 2018 | $353,000 | +4.7% | 25,717 | +16.0% | 0.00% | 0.0% |
Q3 2018 | $337,000 | -9.4% | 22,164 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $372,000 | -9.5% | 22,164 | -11.9% | 0.00% | 0.0% |
Q1 2018 | $411,000 | +28.0% | 25,148 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $321,000 | +48.6% | 25,148 | +42.1% | 0.00% | 0.0% |
Q3 2017 | $216,000 | +45.9% | 17,700 | 0.0% | 0.00% | – |
Q2 2017 | $148,000 | -6.3% | 17,700 | 0.0% | 0.00% | – |
Q1 2017 | $158,000 | +79.5% | 17,700 | +77.0% | 0.00% | – |
Q4 2016 | $88,000 | -34.3% | 10,000 | -50.0% | 0.00% | – |
Q3 2016 | $134,000 | +282.9% | 20,000 | +100.0% | 0.00% | – |
Q2 2016 | $35,000 | +20.7% | 10,000 | 0.0% | 0.00% | – |
Q1 2016 | $29,000 | -31.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2015 | $42,000 | -8.7% | 10,000 | 0.0% | 0.00% | – |
Q3 2015 | $46,000 | -36.1% | 10,000 | 0.0% | 0.00% | – |
Q2 2015 | $72,000 | -1.4% | 10,000 | 0.0% | 0.00% | – |
Q1 2015 | $73,000 | +55.3% | 10,000 | 0.0% | 0.00% | – |
Q4 2014 | $47,000 | +30.6% | 10,000 | 0.0% | 0.00% | – |
Q3 2014 | $36,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2014 | $45,000 | -4.3% | 10,000 | 0.0% | 0.00% | – |
Q1 2014 | $47,000 | -6.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2013 | $50,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
FBR & Co. | 113,500 | $706,000 | 1.07% |
Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |